Efficacy of Liposomal Bupivacaine Versus 0.25% Bupivacaine for Laparoscopic Urologic Surgery

Completed · Phase 4

Conditions studied: Pain, Postoperative

In brief

A prospective, randomized comparison of bupivacaine to liposomal bupivacaine given by local injection at all the wound sites in patients undergoing robotic-assisted or laparoscopic urologic surgeries in an effort to determine which method reduced postoperative opioid use the most.

Key facts

Study ID

NCT02222129

Run by

Knight, Richard, M.D.

People needed

206

Starts

2012-12-01

Expected to finish

2013-12-01

Last updated by the study team

2015-04-16

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 18-years-old, undergoing laparoscopic urologic surgery.

You may not qualify if…

• Pregnant and/or nursing mothers.
• Allergy to bupivacaine.

Where it is running

• Baptist Health System — San Antonio, Texas, United States
• Methodist Healthcare System — San Antonio, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.